Todd Tushla | Vice President, Investor Relations |
Kevin Gorman | Chief Executive Officer |
Matt Abernethy | Chief Financial Officer |
Eiry Roberts | Chief Medical Officer |
Eric Benevich | Chief Commercial Officer |
Brian Abrahams | RBC Capital |
Paul Matteis | Stifel |
Phil Nadeau | Cowen & Company |
Brian Skorney | Baird |
Josh Schimmer | Evercore ISI |
Neena Bitritto-Garg | Citi |
Jay Olson | Oppenheimer |
Anupam Rama | JPMorgan |
Carter Gould | Barclays |
Myles Minter | William Blair |
Vamil Divan | Mizuho Securities |
Marc Goodman | SVB Leerink |
Laura Chico | Wedbush Securities |
Good day, everyone, and welcome to today's Neurocrine Biosciences Reports First Quarter Results. At this time, all participants are in a listen-only mode. Later, you'll have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note, this call may be recorded. I will be standing by, if you need any assistance.